1998, Number 2
<< Back Next >>
Rev Mex Pediatr 1998; 65 (2)
Sinopsis terapéutica. A propósito del ketotifeno en el tratamiento del asma bronquial
Carbajal UJA, Pastrana HE
Language: Spanish
References: 20
Page: 74-75
PDF size: 468.43 Kb.
ABSTRACT
A short review of antihistaminic in the treatment of asthma, is done; it is mentioned, with special interest the use of ketotifeno.
REFERENCES
Faliner AM, Martin JR, Byrne OP, Wiedemann PH. Asma: terapéutica en la década de 1990. Atención Médica México 1991: 1-17.
Bailey CW, Chung F, Lemaqnsker, Reed ECH. Asma: Mejor diagnóstico y control. Atención Médica México 1995: 11-27.
Estadísticas de egresos hospitalarios. Subdirección Médica IMSS. México D.F. Departamento de estadística 1990.
Martínez-Cairo CS, Salas RM, Segura MN. Los aspectos epidemiológicos del asam bronquial en la República Mexicana. Gac Med Mex 1995; 131: 277-282.
Soto QM, Sánchez LF. Factores asociados al asma en Costa Rica: A propósito de un estudio epidemiológico. Rev Mex Pediat 1996; 63: 158-163.
Vargas HM, Sienra MJ, Díaz MG y col. Aspectos epidemiológicos del asma infantil en México. Gac Med Mex 1996; 132: 255-265.
Ter Laak AM, Kelder GM, Bast A, Timmerman H. Is thene a differencie in the affinity of histamine H-I receptor antagonists for CNS and periphenal receptors? an in vitro study. EVR J Pharmacol 1993; 232: 199-205.
Ruat M, Bouthenat ML, Schwantz JC, Ganellin CR. Histamine H-I receptor heart: unique electrophonetic, morbility and autoradographic localization. J Neurochem 1990; 55: 379-385.
Simons EF, Simons KJ. Anthistamines. In: Middleton E. Reedd ChR, Ellis EF, Adkinson NF, Yungingen JW, Busse WW. Allergy principles and practice, 4th ed. St Louis Missouri: Mosby 1993; 856-892.
Chowdhuny BA, Lanomer MA, Fraser CM, Cloning of a gene enconding the human H-I histamine receptor. J Allergy Clin Immunol 1994; 93: 215-217.
Zhang MO, Laak AM, Timmerman H. Structure-activity relationships whitin a series of analogues of histamine H-L antagonist terfenaide. Evr J Med Chem 1993; 28: 165-73.
White MV, The role of histamine in allergic disease. J Allergy Clin Immunol 1990; 86: 599-605.
Simons FER, Murray HE, Simons FJ. Cetirizine and hidroxysine concentrations in human skin. J Allergy Clin Immunol 1994; 93: 222-27.
Nacleiro RM, Kagey SA, Linchtenstein LM, Freidhoff L, Pround D. Terfenodine, and H-I inhibits histamine release in vivo in the human. Am Rev Respir Dis 1990; 142: 167-171.
Jansens MML. Astemizole; a nonsedatin antihistamine with fast and sustained activity. Clin Rev Allergy 1992; 11: 35-63.
Clissold SP, Sorkin EM, Goakl. Loratadine a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1989; 37: 42-57.
Spender CM, Fausd D, Peters DH. Ceftrizine: a reappraisal of its pharmacological properties and therapeutics in selected allergic disorders. Drugs 1993; 46: 1055-80.
Ocaña H, Rubio M, Arrizabalaga R. Estudio abierto de la eficacia y tolerancia del ketotifeno en comprimidos de liberación prolongada en rinitis alérgica. An ORL Mex 1996; 41: 13-7.
Huerta LJ. Ketotifeno en las enfermedades alérgicas. Rev Alergia Mex 1991; 36: 151-7.
Espinoza AJ, Ramírez LM. Manejo del asma bronquial y rinitis alérgica en el niño mediante un programa de control ambiental y educación familiar. Rev Med IMSS (Mex) 1994; 32: 447-51.